COR vs WAT · P/E 21, rev $321.33B vs P/E 32, rev $1.65B
Cencora Inc. (COR) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported WAT revenue for 2026-07-04 was $1.65B. Net income was -$136.0M. Revenue was up 29.8% from 2026-04-04 to 2026-07-04. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
COR currently screens at market cap $53.91B and trailing P/E 21.2. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the COR and WAT stock pages for the full models.
Not investment advice.